vTv Therapeutics Inc.

VTVT

NASDAQ

Healthcare

Biotechnology

High Point, NC, US23 employeesvtvtherapeutics.com

$41.20

+0.67(1.64%)

Mkt Cap $108M

$14.00

$42.72

52-Week Range

At a Glance

AI-generated

vTv Therapeutics Inc.

Revenue breakdown: Reportable Segment (100%).

8-K

vTv Therapeutics Inc. filed an 8-K on March 10, 2026, disclosing an Investor Presentation dated March 2026 as Exhibit 99.1 under Item 7.01, which is not deemed 'filed' for purposes of Section 18 of the Exchange Act. Item 9.01 lists the exhibits including the presentation and cover page interactive data.

$108M

Market Cap

-$7.5K

Revenue

-$8M

Net Income

Employees23

Fundamentals

How The Business Makes Money

Revenue by Segment

Reportable Segment100%($1M)

Activity

What Changed Recently

Financial Results

Mar 9, 2026

Results of Operations and Financial Condition On March 10, 2026, vTv Therapeutics Inc. issued a press release to announce its financial results for the fiscal y

Material Agreement

Feb 1, 2026

Entry into a Material Definitive Agreement. On January 30, 2026, vTv Therapeutics LLC (“vTv LLC” or the "Company"), a subsidiary of vTv Therapeutics Inc., enter

Regulation FD

Mar 9, 2026

(including Exhibit 99.1) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities of, Section 18 of the Exchange Act, nor shal

Regulation FD

Feb 25, 2026

(including Exhibit 99.1) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities of, Section 18 of the Exchange Act, nor shal

Peer Companies

Company	Price	Change	Market Cap	P/E
FBIOFortress Biotech, Inc.	$2.56	+3.64%	$79M	20.4
GANXGain Therapeutics, Inc.	$1.84	-4.90%	$78M	-3.4
INKTMiNK Therapeutics, Inc.	$10.68	+1.04%	$50M	-3.2
HOWLWerewolf Therapeutics, In...	$1.00	+4.86%	$49M	-0.5
OSTXOS Therapies Incorporated	$1.37	+0.74%	$48M	—
SPRBSpruce Biosciences, Inc.	$71.00	+2.11%	$41M	-1.2
NRXPNRx Pharmaceuticals, Inc.	$2.20	+1.85%	$38M	-1.0
CRVOCervoMed Inc.	$4.10	+2.50%	$38M	-1.4

Analyst View

Company Profile

CIK0001641489

ISINUS9183852048

CUSIP918385105

Phone336 841 0300

Address3980 Premier Drive, High Point, NC, 27265, US

SEC EDGAR